Lenz Therapeutics Stock Forecast

Sell candidate since May 29, 2026 Loss -16.20%

The Lenz Therapeutics, Inc. stock price fell by -1.66% on the last day (Tuesday, 16th Jun 2026) from $6.63 to $6.52. During the last trading day the stock fluctuated 3.88% from a day low at $6.45 to a day high of $6.70. The price has fallen in 7 of the last 10 days and is down by -8.56% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -226 thousand shares and in total, 239 thousand shares were bought and sold for approximately $1.56 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $6.31 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -31.97% during the next 3 months and, with a 90% probability hold a price between $4.29 and $5.79 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

LENZ Signals & Forecast

There are mixed signals in the stock today. The Lenz Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.64 and $7.83. A break-up above any of these levels will issue buy signals. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. A buy signal was issued from a pivot bottom point on Thursday, June 11, 2026, and so far it has risen 0.308%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Lenz Therapeutics, Inc. stock

Lenz Therapeutics, Inc. finds support from accumulated volume at $6.50 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.250 between high and low, or 3.88%. For the last week, the stock has had daily average volatility of 5.73%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LENZ) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect Lenz Therapeutics, Inc. to open at $6.56, and during the day (based on 14 day Average True Range), to move between $6.27 and $6.77, which gives a possible trading interval of +/-$0.504 (+/-8.04%) up or down from last closing price. If Lenz Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $6.50 (0.31%) than the resistance at $7.20 (10.43%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Lenz Therapeutics, Inc. stock A Buy?

Lenz Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.449 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 17, 2026 - $6.56 ( 0.562%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk